A detailed history of Fora Capital, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 6,026 shares of CRL stock, worth $1.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
6,026
Previous 8,987 32.95%
Holding current value
$1.2 Million
Previous $1.86 Million 36.05%
% of portfolio
0.15%
Previous 0.23%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $556,549 - $726,303
-2,961 Reduced 32.95%
6,026 $1.19 Million
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $1.85 Million - $2.42 Million
8,987 New
8,987 $1.86 Million
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $1.56 Million - $2.12 Million
8,143 New
8,143 $1.64 Million
Q2 2022

Aug 11, 2022

SELL
$204.13 - $302.4 $477,255 - $707,011
-2,338 Reduced 35.95%
4,166 $891,000
Q1 2022

May 12, 2022

BUY
$255.51 - $362.11 $1.66 Million - $2.36 Million
6,504 New
6,504 $1.89 Million
Q2 2021

Aug 16, 2021

SELL
$294.17 - $371.65 $211,214 - $266,844
-718 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $171,523 - $205,742
-687 Reduced 48.9%
718 $208 Million
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $311,910 - $354,931
1,405 New
1,405 $351,000
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $429,595 - $554,123
-2,447 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $196,799 - $314,176
1,656 Added 209.36%
2,447 $427 Million
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $34,417 - $62,062
348 Added 78.56%
791 $99,000
Q4 2019

Feb 14, 2020

BUY
$126.05 - $152.76 $55,840 - $67,672
443 New
443 $67,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.